{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:32:21Z","timestamp":1793226741412,"version":"4.5.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012359","name":"Promotion and Mutual Aid Corporation for Private Schools of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jtha.2023.07.020","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T21:26:42Z","timestamp":1691011602000},"page":"7-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Thromboinflammation in acute injury: infections, heatstroke, and trauma"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-4088","authenticated-orcid":false,"given":"Toshiaki","family":"Iba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0895-6800","authenticated-orcid":false,"given":"Julie","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2212-5299","authenticated-orcid":false,"given":"Marcel","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3766-4962","authenticated-orcid":false,"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.07.020_bib1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2174\/157016112801784549","article-title":"Crosstalk between inflammation and coagulation: the lessons of sepsis","volume":"10","author":"van der Poll","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jtha.2023.07.020_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.37","article-title":"Disseminated intravascular coagulation","volume":"2","author":"Gando","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtha.2023.07.020_bib3","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms","volume":"133","author":"Jackson","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.020_bib4","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/CCM.0b013e3181c9e31d","article-title":"Microvascular thrombosis and multiple organ dysfunction syndrome","volume":"38","author":"Gando","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib5","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1097\/00003246-200107001-00030","article-title":"Microvascular coagulopathy and disseminated intravascular coagulation","volume":"29","author":"ten Cate","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-18603-0_1","article-title":"Thromboinflammation in therapeutic medicine","volume":"865","author":"Ekdahl","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtha.2023.07.020_bib7","doi-asserted-by":"crossref","first-page":"12258","DOI":"10.1111\/jcmm.15895","article-title":"The role of endothelial shear stress on haemodynamics, inflammation, coagulation and glycocalyx during sepsis","volume":"24","author":"Lupu","year":"2020","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/jth.13911","article-title":"Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis","volume":"16","author":"Iba","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00134-023-06980-6","article-title":"How to manage coagulopathies in critically ill patients","volume":"49","author":"Helms","year":"2023","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/SHK.0000000000000509","article-title":"Circulating microparticles, blood cells, and endothelium induce procoagulant activity in sepsis through phosphatidylserine exposure","volume":"45","author":"Zhang","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.jtha.2023.07.020_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00281-011-0281-9","article-title":"The roles of thrombin and protease-activated receptors in inflammation","volume":"34","author":"Ma","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jtha.2023.07.020_bib12","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.4049\/jimmunol.1500124","article-title":"Regulation of neutrophilic inflammation by proteinase-activated receptor 1 during bacterial pulmonary infection","volume":"194","author":"Jos\u00e9","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jtha.2023.07.020_bib13","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/1873-3468.13881","article-title":"Complement in sepsis-when science meets clinics","volume":"594","author":"Mollnes","year":"2020","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jtha.2023.07.020_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0192623311428478","article-title":"Crosstalk between complement and toll-like receptors","volume":"40","author":"Song","year":"2012","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jtha.2023.07.020_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108264","article-title":"Sepsis roadmap: what we know, what we learned, and where we are going","volume":"210","author":"Kumar","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jtha.2023.07.020_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MOH.0000000000000605","article-title":"The interaction between the complement system and hemostatic factors","volume":"27","author":"Oncul","year":"2020","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jtha.2023.07.020_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"NETosis, complement, and coagulation: a triangular relationship","volume":"16","author":"de Bont","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jtha.2023.07.020_bib18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.intimp.2013.06.034","article-title":"Neutrophil cell surface receptors and their intracellular signal transduction pathways","volume":"17","author":"Futosi","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jtha.2023.07.020_bib19","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.immuni.2011.09.020","article-title":"RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome","volume":"35","author":"Duprez","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jtha.2023.07.020_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/aps.2011.200","article-title":"Role of G protein-coupled receptors in inflammation","volume":"33","author":"Sun","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jtha.2023.07.020_bib21","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1111\/jth.15852","article-title":"Intracellular communication and immunothrombosis in sepsis","volume":"20","author":"Iba","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/SHK.0b013e318181af2a","article-title":"TLR signaling pathway in patients with sepsis","volume":"30","author":"Salom\u00e3o","year":"2008","journal-title":"Shock"},{"key":"10.1016\/j.jtha.2023.07.020_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2023.07.020_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fimmu.2015.00070","article-title":"Are platelets cells? And if yes, are they immune cells?","volume":"6","author":"Garraud","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2023.07.020_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100116","article-title":"Novel mechanisms of thrombo-inflammation during infection: spotlight on neutrophil extracellular trap-mediated platelet activation","volume":"7","author":"Colicchia","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib26","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.3390\/ijms23073868","article-title":"Beyond hemostasis: platelet innate immune interactions and thromboinflammation","volume":"23","author":"Mandel","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2023.07.020_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0268-960X(93)90024-X","article-title":"Platelet\u00a0alpha-granules","volume":"7","author":"Harrison","year":"1993","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2023.07.020_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI122955","article-title":"Functional significance of the platelet immune receptors GPVI and CLEC-2","volume":"129","author":"Rayes","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.07.020_bib29","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2005-05-1994","article-title":"A\u00a0novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2","volume":"107","author":"Suzuki-Inoue","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.020_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2019.03.018","article-title":"Elevated plasma levels of soluble C-type lectin-like receptor 2 (CLEC2) in patients with thrombotic microangiopathy","volume":"178","author":"Yamashita","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.07.020_bib31","first-page":"2860","article-title":"Soluble C-type lectin-like receptor 2 is a biomarker for\u00a0disseminated intravascular coagulation","volume":"10","author":"Yamamoto","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib32","first-page":"985","article-title":"Elevated plasma soluble C-type lectin-like receptor 2 is associated with the worsening of coronavirus disease 2019","volume":"11","author":"Wada","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0042-1749441","article-title":"Platelet activation and thrombosis in COVID-19","volume":"49","author":"Iba","year":"2023","journal-title":"Semin Thromb Hemost"},{"issue":"22","key":"10.1016\/j.jtha.2023.07.020_bib34","first-page":"00342","article-title":"The role of platelets in heat-related illness and heat-induced coagulopathy","volume":"S0049-3848","author":"Iba","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.07.020_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1144229","article-title":"Endothelial dysfunction and immunothrombosis in sepsis","volume":"14","author":"Maneta","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2023.07.020_bib36","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2174\/1389450120666190715102510","article-title":"Recognition of plasminogen activator inhibitor type 1 as the primary regulator of fibrinolysis","volume":"20","author":"Urano","year":"2019","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jtha.2023.07.020_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13054-018-2292-6","article-title":"The glycocalyx: a novel diagnostic and therapeutic target in sepsis","volume":"23","author":"Uchimido","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2023.07.020_bib38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/jth.14371","article-title":"Derangement of the endothelial glycocalyx in sepsis","volume":"17","author":"Iba","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1164\/rccm.201910-1911TR","article-title":"Endothelial responses in sepsis","volume":"202","author":"Joffre","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13054-021-03524-6","article-title":"Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation","volume":"25","author":"Ito","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2023.07.020_bib41","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00011-020-01401-6","article-title":"The coagulopathy, endotheliopathy, and vasculitis of COVID-19","volume":"69","author":"Iba","year":"2020","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jtha.2023.07.020_bib42","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1172\/JCI97488","article-title":"Tie2 protects the vasculature against thrombus formation in systemic inflammation","volume":"128","author":"Higgins","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.07.020_bib43","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.3390\/ijms22052721","article-title":"A\u00a0narrative review on plasminogen activator inhibitor-1 and its (patho)physiological role: to target or not to target?","volume":"22","author":"Sillen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2023.07.020_bib44","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1378\/chest.101.3.816","article-title":"Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies","volume":"101","author":"Fourrier","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2023.07.020_bib45","doi-asserted-by":"crossref","first-page":"14270","DOI":"10.1096\/fj.201901363RRR","article-title":"DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma","volume":"33","author":"Cruz","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.jtha.2023.07.020_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40560-023-00656-5","article-title":"Sepsis-related coagulopathy treatment based on the disseminated intravascular coagulation diagnostic criteria: a post-hoc analysis of a prospective multicenter observational study","volume":"11","author":"Wada","year":"2023","journal-title":"J\u00a0Intensive Care"},{"key":"10.1016\/j.jtha.2023.07.020_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017046","article-title":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey","volume":"7","author":"Iba","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtha.2023.07.020_bib48","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/jth.14482","article-title":"Scientific and Standardization Committee on DIC of the International Society on Thrombosis and Haemostasis. Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation","volume":"17","author":"Iba","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib49","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/jth.14578","volume":"17","author":"Iba","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib50","article-title":"Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy","volume":"14","author":"Huang","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jtha.2023.07.020_bib51","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jtha.2022.11.032","article-title":"Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasis on vascular endothelium-related biomarkers in disseminated intravascular coagulation","volume":"21","author":"Iba","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/ijlh.13500","article-title":"COVID-19: thrombosis, thromboinflammation, and anticoagulation considerations","volume":"43","author":"Levy","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2023.07.020_bib53","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.020_bib54","first-page":"191","article-title":"Proposal of the definition for COVID-19-associated coagulopathy","volume":"10","author":"Iba","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib55","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/CIRCRESAHA.120.317447","article-title":"The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications","volume":"127","author":"McFadyen","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2023.07.020_bib56","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11239-021-02583-4","article-title":"Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy","volume":"53","author":"Cacciola","year":"2022","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2023.07.020_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.851497","article-title":"Plasma markers of neutrophil extracellular trap are linked to survival but not to pulmonary embolism in COVID-19-related ARDS patients","volume":"13","author":"Pr\u00e9vel","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2023.07.020_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76781-0","article-title":"The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19)","volume":"10","author":"Arcanjo","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2023.07.020_bib59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12575-021-00142-y","article-title":"Anatomical and pathological observation and analysis of SARS and COVID-19: microthrombosis is the main cause of death","volume":"23","author":"Chen","year":"2021","journal-title":"Biol Proced Online"},{"key":"10.1016\/j.jtha.2023.07.020_bib60","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1152\/japplphysiol.00301.2010","article-title":"Heat stroke: role of the systemic inflammatory response","volume":"109","author":"Leon","year":"2010","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.jtha.2023.07.020_bib61","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-0038-1650685","article-title":"Activation of coagulation and fibrinolysis in heatstroke","volume":"76","author":"Bouchama","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101276","article-title":"Heatstroke-induced coagulopathy: biomarkers, mechanistic insights, and patient management","volume":"44","author":"Iba","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jtha.2023.07.020_bib63","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s12192-010-0172-3","article-title":"Hsp-72, a candidate prognostic indicator of heatstroke","volume":"15","author":"Dehbi","year":"2010","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.jtha.2023.07.020_bib64","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12974-021-02179-y","article-title":"NLRP3 ablation enhances tolerance in heat stroke pathology by inhibiting IL-1\u03b2-mediated neuroinflammation","volume":"18","author":"Zhang","year":"2021","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.jtha.2023.07.020_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110489","article-title":"Proteomic analysis of extracellular vesicles released from heat-stroked hepatocytes reveals promotion of programmed cell death pathway","volume":"129","author":"Li","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jtha.2023.07.020_bib66","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/jth.14690","article-title":"Defining trauma-induced coagulopathy with respect to future implications for patient management: communication from the SSC of the ISTH","volume":"18","author":"Moore","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib67","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1038\/s41467-021-24644-1","article-title":"A\u00a0novel RyR1-selective inhibitor prevents and rescues sudden death in mouse models of malignant hyperthermia and heat stroke","volume":"12","author":"Yamazawa","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2023.07.020_bib68","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury","volume":"361","author":"Bosch","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib69","doi-asserted-by":"crossref","first-page":"17444","DOI":"10.1073\/pnas.1904978116","article-title":"Histone H4 induces platelet ballooning and microparticle release during trauma hemorrhage","volume":"116","author":"Vulliamy","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2023.07.020_bib70","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/jth.14480","article-title":"Disseminated intravascular coagulation in cardiac arrest and resuscitation","volume":"17","author":"Gando","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib71","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1213\/ANE.0000000000004234","article-title":"Fibrinolysis shutdown in trauma: historical review and clinical implications","volume":"129","author":"Moore","year":"2019","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtha.2023.07.020_bib72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jamcollsurg.2019.03.015","article-title":"Does tranexamic acid improve clot strength in severely injured patients who have elevated fibrin degradation products and low fibrinolytic activity, measured by thrombelastography?","volume":"229","author":"Moore","year":"2019","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.jtha.2023.07.020_bib73","article-title":"Mechanisms and management of the coagulopathy of trauma and sepsis: TIC, SIC, and DIC","author":"Iba","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib74","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib75","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1002\/ams2.659","article-title":"The Japanese Clinical Practice Guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020)","volume":"8","author":"Egi","year":"2021","journal-title":"Acute Med Surg"},{"key":"10.1016\/j.jtha.2023.07.020_bib76","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1097\/PCC.0000000000002578","article-title":"Outcome of early hemostatic intervention in children with sepsis and nonovert disseminated intravascular coagulation admitted to PICU: a randomized controlled trial","volume":"22","author":"El-Nawawy","year":"2021","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib77","doi-asserted-by":"crossref","DOI":"10.5812\/aapm.115938","article-title":"Effect of nebulized heparin on weaning off intubated patients with acute respiratory distress syndrome (ARDS) admitted to intensive care unit (ICU): a randomized clinical trial","volume":"11","author":"Olapour","year":"2021","journal-title":"Anesth Pain Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib78","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.290.2.238","article-title":"Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial","volume":"290","author":"Abraham","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2023.07.020_bib79","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib80","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2023.07.020_bib81","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1538-7836.2005.01697.x","article-title":"KyberSept investigators. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation","volume":"4","author":"Kienast","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib82","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2023.07.020_bib83","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13054-019-2587-2","article-title":"Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis","volume":"23","author":"Yamakawa","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2023.07.020_bib84","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/jth.12643","article-title":"Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study","volume":"12","author":"Tagami","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib85","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1160\/TH15-01-0053","article-title":"Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis","volume":"114","author":"Tagami","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib86","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/jth.13946","article-title":"Optimal patient selection for anticoagulant therapy in sepsis: an evidence-based proposal from Japan","volume":"16","author":"Umemura","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib87","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/jth.15808","article-title":"ISTH guidelines for antithrombotic treatment in COVID-19","volume":"20","author":"Schulman","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib88","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"ATTACC Investigators; ACTIV-4a Investigators; REMAP-CAP Investigators. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19","volume":"385","author":"Lawler","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib89","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1055\/s-0039-1700520","article-title":"Treatment with antithrombin or thrombomodulin and mortality from heatstroke-induced disseminated intravascular coagulation: a nationwide observational study","volume":"45","author":"Ohbe","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib90","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/CCM.0b013e3181b4275c","article-title":"Antiplatelet drugs and outcome in mixed admissions to an intensive care unit","volume":"38","author":"Winning","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib91","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/CCM.0b013e318246b9df","article-title":"Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis","volume":"40","author":"Eisen","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib92","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13054-018-2169-8","article-title":"Septic shock-3 vs 2: an analysis of the ALBIOS study","volume":"22","author":"Vasques","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2023.07.020_bib93","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00134-015-4171-9","article-title":"Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: a propensity-matched analysis","volume":"42","author":"Wiewel","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib94","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40360-016-0047-z","article-title":"Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study","volume":"17","author":"Al Harbi","year":"2016","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jtha.2023.07.020_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2022.154015","article-title":"Antiplatelet pretreatment and mortality in patients with severe sepsis: a secondary analysis from a multicenter, prospective survey of severe sepsis in Japan","volume":"69","author":"Kobayashi","year":"2022","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.jtha.2023.07.020_bib96","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02117-21","article-title":"Impact of clopidogrel on clinical outcomes in patients with Staphylococcus aureus bacteremia: a national retrospective cohort study","volume":"66","author":"Caffrey","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jtha.2023.07.020_bib97","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1160\/TH03-04-0233","article-title":"Blockade of GPIIb\/IIIa by eptifibatide and tirofiban does not alter tissue factor induced thrombin generation in human endotoxemia","volume":"90","author":"Derhaschnig","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib98","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01825-0","article-title":"Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.07.020_bib99","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jama.2021.23605","article-title":"Effect of P2Y12 inhibitors on survival free of organ support among non-critically ill hospitalized patients with COVID-19: a randomized clinical trial","volume":"327","author":"Berger","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2023.07.020_bib100","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.2022.2910","article-title":"REMAP-CAP Writing Committee for the REMAP-CAP Investigators. Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial","volume":"327","author":"Bradbury","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2023.07.020_bib101","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0002-9440(10)61133-9","article-title":"Anti-c5a ameliorates coagulation\/fibrinolytic protein changes in a rat model of sepsis","volume":"160","author":"Laudes","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtha.2023.07.020_bib102","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1038\/mt.2013.178","article-title":"A\u00a0novel C5a-neutralizing mirror-image (l-)aptamer prevents organ failure and improves survival in experimental sepsis","volume":"21","author":"Hoehlig","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.jtha.2023.07.020_bib103","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/ALN.0000000000003149","article-title":"Neutralizing complement C5a protects mice with pneumococcal pulmonary sepsis","volume":"132","author":"M\u00fcller-Redetzky","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtha.2023.07.020_bib104","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1182\/blood-2010-02-269746","article-title":"Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis","volume":"116","author":"Silasi-Mansat","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.020_bib105","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1111\/jcmm.12667","article-title":"Complement inhibition decreases early fibrogenic events in the lung of septic baboons","volume":"19","author":"Silasi-Mansat","year":"2015","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100590","article-title":"Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: a proof-of-concept study","volume":"28","author":"Annane","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jtha.2023.07.020_bib107","first-page":"S2213","article-title":"Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial","author":"Annane","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib108","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1055\/s-0038-1655767","article-title":"Inhibition of protease-activated receptor (PAR1) reduces activation of the endothelium, coagulation, fibrinolysis and inflammation during human endotoxemia","volume":"118","author":"Schoergenhofer","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.866113","article-title":"Sulodexide significantly improves endothelial dysfunction and alleviates chest pain and palpitations in patients with long-COVID-19: insights from TUN-EndCOV study","volume":"9","author":"Charfeddine","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106334","article-title":"Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial","volume":"57","author":"Faqihi","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jtha.2023.07.020_bib111","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/SHK.0b013e318142c4e8","article-title":"Effects of the pan-selectin antagonist bimosiamose (TBC1269) in experimental human endotoxemia","volume":"29","author":"Mayr","year":"2008","journal-title":"Shock"},{"key":"10.1016\/j.jtha.2023.07.020_bib112","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"Dequin","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib113","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamainternmed.2023.0258","article-title":"Comparative effectiveness of fludrocortisone and hydrocortisone vs hydrocortisone alone among patients with septic shock","volume":"183","author":"Bosch","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib114","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1186\/s13063-020-04488-8","article-title":"Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Desilles","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.jtha.2023.07.020_bib115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with Covid-19 pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib116","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.07.020_bib117","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1056\/NEJMoa2028836","article-title":"Efficacy of tocilizumab in patients hospitalized with Covid-19","volume":"383","author":"Stone","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib118","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2213-2600(21)00081-3","article-title":"Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial","volume":"9","author":"Soin","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib119","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe Covid-19 pneumonia","volume":"384","author":"Rosas","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib120","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S2213-2600(21)00377-5","article-title":"Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial","volume":"9","author":"Declercq","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib121","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe sepsis or septic shock","volume":"370","author":"Caironi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.07.020_bib122","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1186\/s13054-014-0702-y","article-title":"Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials","volume":"18","author":"Xu","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2023.07.020_bib123","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.3390\/nu14204415","article-title":"Biological effects of intravenous vitamin C on neutrophil extracellular traps and the endothelial glycocalyx in patients with sepsis-induced ARDS","volume":"14","author":"Qiao","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jtha.2023.07.020_bib124","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13054-020-2799-5","article-title":"Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock","volume":"24","author":"Stahl","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2023.07.020_bib125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13054-022-04003-2","article-title":"Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial","volume":"26","author":"Stahl","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2023.07.020_bib126","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211053313","article-title":"Therapeutic plasma exchange protects patients with sepsis-associated disseminated intravascular coagulation by improving endothelial function","volume":"27","author":"Weng","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.07.020_bib127","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000526446","article-title":"Effect of hemadsorption therapy in critically ill patients with COVID-19 (CYTOCOV-19): a prospective randomized controlled pilot trial","volume":"52","author":"Jarczak","year":"2023","journal-title":"Blood Purif"},{"key":"10.1016\/j.jtha.2023.07.020_bib128","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/CIRCULATIONAHA.121.056940","article-title":"Cytokine hemoadsorption during cardiac surgery versus standard surgical care for infective endocarditis (REMOVE): results from a multicenter randomized controlled trial","volume":"145","author":"Diab","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2023.07.020_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2020.07.025","article-title":"Adsorptive granulocyte and monocyte apheresis: a potentially relevant therapeutic option for COVID-19","volume":"99","author":"Kanekura","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jtha.2023.07.020_bib130","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/17474124.2022.2100759","article-title":"Targeting neutrophils in inflammatory bowel disease: revisiting the role of adsorptive granulocyte and monocyte apheresis","volume":"16","author":"Bamias","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jtha.2023.07.020_bib131","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/1744-9987.13594","article-title":"Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: a multicenter cohort study","volume":"25","author":"Ishiguro","year":"2021","journal-title":"Ther Apher Dial"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623005834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623005834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:41:11Z","timestamp":1761536471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623005834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1538783623005834"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.07.020","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thromboinflammation in acute injury: infections, heatstroke, and trauma","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}